Tumor-Resilient T-cell Signature Predicts Immunotherapy Response

Cancer Discov. 2022 Jul 6;12(7):OF18. doi: 10.1158/2159-8290.CD-RW2022-089.

Abstract

A computational model of resilient T cells predicts immunotherapy response via transcriptomic data.

MeSH terms

  • Humans
  • Immunotherapy*
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics
  • Prognosis
  • T-Lymphocytes
  • Transcriptome